GlassScriptPhysician profile
Bruce D Stamos
NPI 1669453650
$4,721.59
in general payments reported to CMS, 2019-2025
25 companies · $462 in 2025
The $462 reported for 2025 was less than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
See the full distribution for Sports Medicine (Orthopaedic Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $200 · 2020: $173 · 2021: $205 · 2022: $1,425 · 2023: $1,943 · 2024: $314 · 2025: $462.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,766 · Travel and Lodging: $953.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,765.66 |
| Travel and Lodging | $953.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,923.58 | 2021-2025 | Blueprint Patient Specific Instrumentation, Gamma, Aequalis Perform |
| Seapearl East, INC | $1,244.33 | 2022-2024 | |
| Ferring Pharmaceuticals INC. | $345.28 | 2019-2025 | Euflexxa |
| Depuy Synthes Sales INC. | $173.81 | 2019-2025 | Monovisc, Orthovisc |
| Organogenesis INC. | $151.17 | 2021-2024 | |
| Bioventus LLC | $135.91 | 2024-2025 | Durolane |
| Wright Medical Technology, INC. | $116.05 | 2020 | |
| Zimmer Biomet Holdings, INC. | $111.92 | 2023-2024 | Gel-One Cross-Linked Hyaluronate |
| Smith+Nephew, INC. | $82.42 | 2019-2025 | Renasys Touch |
| Acumed LLC | $79.68 | 2019-2022 | |
| Pacira Pharmaceuticals Incorporated | $49.69 | 2024-2025 | Exparel, Zilretta |
| Baxter Healthcare | $41.46 | 2021 | |
| Fidia Pharma USA INC. | $35.35 | 2024-2025 | Hymovis |
| Kowa Pharmaceuticals America, INC. | $28.18 | 2022 | |
| Pfizer INC. | $28.10 | 2019-2020 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Si-Bone, INC. | $27.45 | 2019 | |
| Avanos Medical | $27.32 | 2023 | Trivisc Sodium Hyaluronate |
| Linvatec Corporation | $18.68 | 2023 | Biobrace 23mm |
| Djo, LLC | $16.93 | 2025 | Donjoy |
| Abbott Laboratories | $14.66 | 2020 | |
| Ebi, LLC | $14.47 | 2025 | Biomet Spinalpak Non-Invasive Spine Fusion Stimulator System |
| Highridge Medical LLC | $14.47 | 2025 | Biomet Spinalpak Non-Invasive Spine Fusion Stimulator System |
| Scilex Pharmaceuticals INC. | $14.09 | 2019 | |
| Next Science LLC | $13.33 | 2021 | |
| Sanofi-Aventis U.S. LLC | $13.26 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bruce Stamos listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.